Operating Segments (Tables)

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Schedule of operating segments

	Three Months Ended
	September 30,
		2020			2019
Revenues
Public Health Solutions	$	544,466		$	991,087
Specialized BioTherapeutics		64,345			263,817
Total	$	608,811		$	1,254,904
(Loss) Income from Operations
Public Health Solutions	$	(6,369	)	$	72,491
Specialized BioTherapeutics		(643,793	)		(1,926,883	)
Corporate		(1,162,615	)		(912,207	)
Total	$	(1,812,777	)	$	(2,766,599	)
Amortization and Depreciation Expense
Public Health Solutions	$	6,651		$	4,312
Specialized BioTherapeutics		3,201			4,141
Corporate		7,335			6,448
Total	$	17,187		$	14,901
Other Income, Net
Specialized BioTherapeutics	$	22,131		$	8,809
Corporate		486			37,007
Total	$	22,617		$	45,816
Share-Based Compensation
Public Health Solutions	$	8,377		$	8,072
Specialized BioTherapeutics		18,962			18,609
Corporate		39,233			54,846
Total	$	66,572		$	81,527

	Nine Months Ended
	September 30,
		2020			2019
Revenues
Public Health Solutions	$	1,921,284		$	2,767,304
Specialized BioTherapeutics		117,369			1,177,351
Total	$	2,038,653		$	3,944,655
(Loss) Income from Operations
Public Health Solutions	$	(215,608	)	$	267,601
Specialized BioTherapeutics		(9,810,296	)		(4,725,774	)
Corporate		(3,074,534	)		(2,773,380	)
Total	$	(13,100,438	)	$	(7,231,553	)
Amortization and Depreciation Expense
Public Health Solutions	$	21,272		$	13,030
Specialized BioTherapeutics		9,438			12,986
Corporate		21,925			11,876
Total	$	52,635		$	37,892
Other Income, Net
Specialized BioTherapeutics	$	90,838		$	11,479
Corporate		24,450			125,467
Total	$	115,288		$	136,946
Share-Based Compensation
Public Health Solutions	$	26,219		$	21,340
Specialized BioTherapeutics		63,213			58,611
Corporate		121,834			154,041
Total	$	211,266		$	233,992

		As of		As of
		September 30,		December 31,
		2020		2019
Identifiable Assets
Public Health Solutions	$	357,798	$	1,018,673
Specialized BioTherapeutics		54,944		41,705
Corporate		12,837,336		6,714,982
Total	$	13,250,078	$	7,775,360